78 related articles for article (PubMed ID: 2411437)
1. Comparative study of different types of treatments in chronic active hepatitis.
Bahgat MH; Sabbour MS; Osman LM; Ghali AF; Gadallah MA
Chemioterapia; 1985 Jun; 4(3):227-35. PubMed ID: 2411437
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of chronic active hepatitis (HBsAg +,HBeAg +) with isoprinosine. Clinical evaluation].
Cianciara J; Loch T; Babiuch L; Dabrowska-Bernstein B; Stasiak A; Dabrowski M; Pawińska A
Pol Tyg Lek; 1988 Sep; 43(37):1195-8. PubMed ID: 2470069
[No Abstract] [Full Text] [Related]
3. [Evaluation of the treatment of chronic active hepatitis (HBsAg+) with isoprinosine. II. Immunological studies].
Dabrowska-Bernstein B; Stasiak A; Dabrowski M; Pawińska A; Cianciara J; Loch T; Babiuch L
Pol Tyg Lek; 1990 Apr 16-30; 45(16-18):347-51. PubMed ID: 1700402
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive therapy in chronic active hepatitis (CAH). A multicentric retrospective study on 867 patients. A report from a study group for CAH of the Italian Association for the study of the liver.
Giusti G; Piccinino F; Galanti B; Sagnelli E; Ruggiero G; Gallo C
Hepatogastroenterology; 1984 Feb; 31(1):24-9. PubMed ID: 6698485
[TBL] [Abstract][Full Text] [Related]
5. [Experience with immunosuppressive therapy of active chronic hepatitis using long-term multiple corticoids].
Tremolada F; Realdi G; Noventa F; Antona C; Ruol A
Clin Ter; 1985 Jan; 112(2):121-30. PubMed ID: 4017455
[No Abstract] [Full Text] [Related]
6. [Treatment of autoimmune chronic active hepatitis and of primary biliary cirrhosis].
Renner EL
Schweiz Med Wochenschr; 1994 Mar; 124(12):495-501. PubMed ID: 8159985
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic active hepatitis (CAH): a retrospective review of 130 patients.
Giusti G; Ruggiero G; Galanti B; Piccinino F; Russo M; Galante D; Sagnelli E; Utili R; Pasquale G; Nardiello S; Aloisio V
Hepatogastroenterology; 1981 Oct; 28(5):245-9. PubMed ID: 7047337
[TBL] [Abstract][Full Text] [Related]
8. [Immunosuppressive treatment of patients with chronic active HBsAg positive hepatitis].
Tanno H; Fay O; Roldán L; Vorovioff J
Acta Gastroenterol Latinoam; 1982; 12(4):323-32. PubMed ID: 7185230
[TBL] [Abstract][Full Text] [Related]
9. [Markers of chronic hepatitis B in children after completion of therapy with isoprinosine].
Kowalik-Mikołajewska B; Barszcz T; Ladyzyńska E; Wojnarowski M
Pol Tyg Lek; 1993 Mar 15-29; 48(11-13):263-4. PubMed ID: 7694263
[TBL] [Abstract][Full Text] [Related]
10. [Course of chronic virus hepatitis B in children and attempts at modifying its treatment].
Kowalik-Mikołajewska B
Pol Tyg Lek; 1993 Mar 15-29; 48(11-13):258-60. PubMed ID: 7694262
[TBL] [Abstract][Full Text] [Related]
11. [Therapy of chronic hepatitis].
Schmid M
Schweiz Med Wochenschr; 1980 Sep; 110(38):1365-9. PubMed ID: 6158757
[TBL] [Abstract][Full Text] [Related]
12. Intramuscular natural beta interferon in the treatment of chronic hepatitis B: a multicentre trial. Italian Hepatitis B Study Group.
Capalbo M; Palmisano L; Bonino F; Pellas C; Maset J
Ital J Gastroenterol; 1994 Jun; 26(5):238-41. PubMed ID: 7919465
[TBL] [Abstract][Full Text] [Related]
13. [Long-term study of patients with active chronic hepatitis treated with leukocyte interferon].
Sotto A; Selman E; Grá B; Arencibia I; Morales M; Llanio R
Acta Gastroenterol Latinoam; 1988; 18(4):249-52. PubMed ID: 3255220
[TBL] [Abstract][Full Text] [Related]
14. Corticosteroid therapy for chronic active hepatitis.
Am J Gastroenterol; 1984 Jul; 79(7):573-5. PubMed ID: 6377879
[No Abstract] [Full Text] [Related]
15. [Diagnosis and therapy of chronic active hepatitis].
Paumgartner G
Schweiz Med Wochenschr; 1978 Jan; 108(4):120-3. PubMed ID: 622540
[TBL] [Abstract][Full Text] [Related]
16. Oral pulse prednisone therapy in the treatment of HBsAg negative chronic active hepatitis.
Chase WF; Winn RE; Mayes GR
Gastroenterology; 1982 Dec; 83(6):1292-6. PubMed ID: 7129032
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive effects of isoprinosine in man: a comparison to chlorambucil effects in multiple sclerosis.
Pompidou A; Rancurel G; Delsaux MC; Meunier C; Telvi L; Cour V; Buge A
Cancer Detect Prev Suppl; 1987; 1():377-83. PubMed ID: 2446758
[TBL] [Abstract][Full Text] [Related]
18. Treatment of chronic hepatitis B with human lymphoblastoid interferon: results of a controlled trial.
Mazzella G; Villanova N; Abdu-Ahmed M; Barbara L; Saracco G; Rizzetto M; Cancellieri C; Roda E
Chemioterapia; 1988 Dec; 7 Suppl 3():12-4. PubMed ID: 3073868
[TBL] [Abstract][Full Text] [Related]
19. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
[TBL] [Abstract][Full Text] [Related]
20. [Immunosuppressive therapy of chronic active hepatitis: results of a long-term follow-up].
Musca A; Cordova C; Barnaba V; Levrero M; Zaccari C; Trinchieri F; Gnecchi M
Clin Ter; 1983 Jun; 105(5):403-9. PubMed ID: 6872479
[No Abstract] [Full Text] [Related]
[Next] [New Search]
